VTE in Pregnancy: Guidance for Healthcare Professionals

Why VTE Matters

Pregnancy is a naturally hypercoagulable state, an evolutionary adaptation to limit blood loss at delivery. It comes at a cost: pregnant women have an overall risk approximately 4–5 times the VTE risk of non-pregnant women of the same age, although the risk is low in the first trimester, double the non pregnant risk and rises gradually, rising further in the postpartum period, when the risk is 60 times the non-pregnant risk1.

Venous thromboembolism is the leading cause of maternal death in the UK.2  Of note the 2024 MBRRACE report noted that unexpectedly 25% of all deaths occurred in early pregnancy, many before women were seen in Maternity Care in the UK- “booking” does not normally occur before 8-10 weeks. This led to NHS England to ask a team of healthcare professionals and patient representatives to find a solution for this period. This led to the development of the early pregnancy risk questionnaire/assessment tool which lives on the Thrombosis UK website, allowing women to self-assess their risk – see earlypregnancy | Thrombosis UK . This was also translated into Element 1 of the Maternal Care bundle released in January 2026 (see NHS England » The Maternal Care Bundle) allowing healthcare professionals who see pregnant women in early pregnancy to assess their risk.

Assessing VTE Risk

VTE risk should be assessed as early as possible in pregnancy and whenever clinical circumstances change, including at maternity booking, hospital admission, around birth and postpartum. In practice, if women are seen outside Maternity Care in early pregnancy, they should be risk assessed with either the early pregnancy risk assessment tool or RCOG tool.

Consider:

  • Pre-existing factors: previous VTE, thrombophilia, family history, obesity, age, parity and relevant medical comorbidities
  • Obstetric factors: hyperemesis gravidarum, caesarean birth, pre-eclampsia, multiple pregnancy, assisted reproduction, postpartum haemorrhage and preterm birth
  • Transient factors: infection, immobility, dehydration and surgery

Previous VTE, high-risk thrombophilia or APS should prompt consideration of early specialist input (see early pregnancy risk assessment tool).

Important 2026 RCOG update

In September 2026, RCOG issued an interim update to Green-top Guideline No. 37a, introducing:

  • LMWH throughout pregnancy and for six weeks postpartum for women with BMI ≥50 kg/m² at booking
  • revised weight-based LMWH dosing
  • updated VTE risk assessment scoring so that the RCOG guidance is in harmony with the evidence based early pregnancy risk assessment tool

Clinicians should use GTG 37a alongside the September 2026 position statement until the updated guideline is published.

Pregnancy loss and abortion care: VTE risk assessment remains important following miscarriage or termination of pregnancy. All the abortion services are implementing the use of the early pregnancy tool.

Thromboprophylaxis: Who, What, When and How Long?

Who?
Use the early pregnancy risk assessment tool or current RCOG VTE risk assessment to determine whether thromboprophylaxis is indicated. Previous VTE and thrombophilia may require individualised specialist management.

What?
Low molecular weight heparin (LMWH) is the recommended pharmacological thromboprophylaxis in pregnancy. Dosing is weight-based. Refer to the early pregnancy tool and current RCOG guidance and September 2026 position statement, alongside local guidance.  

When?
Start LMWH as soon as possible once an indication is identified. Women receiving antenatal LMWH should have a clear plan for labour and birth, including when to stop LMWH, implications for regional anaesthesia and when to restart following delivery.

How long?
Duration depends on the woman’s individual risk and may range from treatment while a transient risk factor persists to 10 days or six weeks postpartum. VTE risk should be reassessed after birth.

Supportive measures: Encourage mobilisation and adequate hydration. Where LMWH is contraindicated, discuss urgently with local experts  .

 

Always refer to the early pregnancy risk assessment tool or latest RCOG Green-top Guideline No. 37a and September 2026 position statement, together with local guidance, for current risk thresholds, LMWH dosing and duration.

The Patient Experience

“Do I really need this?” “Will it affect my baby?” “What happens if I miss a dose?”

Daily injections, concerns about the baby and uncertainty around labour can affect adherence. A missed dose may reflect a practical or emotional barrier rather than a lack of motivation.

Ensure women understand:

Remember that adherence may become more difficult after birth and additional support may be needed.

Suspected VTE

Maintain a low threshold for investigating VTE during pregnancy and postpartum. Unilateral leg pain and/or swelling, unexplained breathlessness, syncope, chest pain or tachycardia should prompt urgent clinical assessment.

Suspected VTE requires prompt objective investigation. D-dimer testing is not currently recommended by RCOG for the investigation of acute VTE in pregnancy.

Whilst the RCOG guidance is being updated we suggest using the new 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines | Circulation, which has a special section on pregnancy.

Please consider referring to the local PERT team as the management of PE has changed enormously in the last ten years, from classification to management, so help from a team dealing in PE everyday is very helpful.

Supporting Good Practice

Reliable VTE prevention requires:

  • consistent risk assessment and reassessment
  • clear documentation of LMWH dose and duration
  • effective handover between antenatal, intrapartum and postnatal teams
  • clear communication with women about their treatment plan

The thromboprophylaxis plan should follow the woman throughout her maternity journey.

Guidelines and Resources

Guidance is evolving. Clinicians should use the latest national or international recommendations alongside local maternity and thrombosis guidance.

References

  1. Heit et al (2005) Trends in the Incidence of Venous Thromboembolism during Pregnancy or Postpartum: A 30 Year Population-Based Study. Annals of Internal Medicine 142(10). https://doi.org/10.7326/0003-4819-143-10-200511150-00006
  2. MBRRACE-UK (2026) Saving Lives, Improving Mothers’ Care: Lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2022–24. Oxford: National Perinatal Epidemiology Unit, University of Oxford.

This guidance has been developed and reviewed by Professor Beverley Hunt OBE, Founder of Thrombosis UK and Co-Chair of Trustees and members of the VTE Specialists Network.

To download a PDF copy, please click the button below

Thrombosis UK VTE Awards
Application form

Applications are accepted on the basis that Thrombosis UK can share the content with external judges who will assist us with assessments. Service models, resources and working processes of successful Thrombosis UK VTE Award winners will be uploaded to the Thrombosis UK website and shared via publications, social media, and other opportunities.

When completing your application form, you should use lay language and answer each question in a concise manner. 

Please keep to any word limits given.

All sections need to be completed, if any section is removed, omitted or incomplete, we cannot process the application.

Applications need to be submitted via email to: [email protected] You will receive a notification of receipt within 48 hours of submission. If you do not receive a notification, please email [email protected]

The closing date for applications is 1st February 2025

We are unable to consider late applications.

Category
Thrombosis UK Award deep vein thrombosis (DVT) pathway award for leading to improved timely diagnosis of thrombosis
Please note there is a separate application form for each category.
DATA PROTECTION

Thrombosis UK has a strict data protection policy that complies with UK data protection law.

Your name and contact details may be stored for up to 12 months in order for correspondence relating to your application be appropriately processed.

 

We wish to make you aware that your name and contact details, as included on your completed application form, will be viewed by the Thrombosis UK appointed Judging Panel solely for the purpose of reviewing and assessing your completed application.  If your nomination is short listed, a representative from Thrombosis UK will then seek your permission to include your name on the summary paragraph included in the awards brochure and on the Thrombosis UK website.

Thrombosis UK takes security and confidentiality very seriously. Your name and contact details will never be passed or shared with any third party or an unauthorised individual. If you have any queries, please contact: [email protected]

Thrombosis UK VTE Awards
Application form

Applications are accepted on the basis that Thrombosis UK can share the content with external judges who will assist us with assessments. Service models, resources and working processes of successful Thrombosis UK VTE Award winners will be uploaded to the Thrombosis UK website and shared via publications, social media, and other opportunities.

When completing your application form, you should use lay language and answer each question in a concise manner. 

Please keep to any word limits given.

All sections need to be completed, if any section is removed, omitted or incomplete, we cannot process the application.

Applications need to be submitted via email to: [email protected] You will receive a notification of receipt within 48 hours of submission. If you do not receive a notification, please email [email protected]

The closing date for applications is 1st February 2025

We are unable to consider late applications.

Category
Thrombosis UK Award for an excellent Quality Improvement programme that advanced practice in thrombosis prevention or management.
Please note there is a separate application form for each category.
DATA PROTECTION

Thrombosis UK has a strict data protection policy that complies with UK data protection law.

Your name and contact details may be stored for up to 12 months in order for correspondence relating to your application be appropriately processed.

 

We wish to make you aware that your name and contact details, as included on your completed application form, will be viewed by the Thrombosis UK appointed Judging Panel solely for the purpose of reviewing and assessing your completed application.  If your nomination is short listed, a representative from Thrombosis UK will then seek your permission to include your name on the summary paragraph included in the awards brochure and on the Thrombosis UK website.

Thrombosis UK takes security and confidentiality very seriously. Your name and contact details will never be passed or shared with any third party or an unauthorised individual. If you have any queries, please contact: [email protected]

Thrombosis UK VTE Awards
Application form

Applications are accepted on the basis that Thrombosis UK can share the content with external judges who will assist us with assessments. Service models, resources and working processes of successful Thrombosis UK VTE Award winners will be uploaded to the Thrombosis UK website and shared via publications, social media, and other opportunities.

When completing your application form, you should use lay language and answer each question in a concise manner. 

Please keep to any word limits given.

All sections need to be completed, if any section is removed, omitted or incomplete, we cannot process the application.

Applications need to be submitted via email to: [email protected] You will receive a notification of receipt within 48 hours of submission. If you do not receive a notification, please email [email protected]

The closing date for applications is 1st February 2025

We are unable to consider late applications.

Category
Thrombosis UK Award for outstanding patient resource, sharing information. about VTE prevention for patients and carers
Please note there is a separate application form for each category.
DATA PROTECTION

Thrombosis UK has a strict data protection policy that complies with UK data protection law.

Your name and contact details may be stored for up to 12 months in order for correspondence relating to your application be appropriately processed.

 

We wish to make you aware that your name and contact details, as included on your completed application form, will be viewed by the Thrombosis UK appointed Judging Panel solely for the purpose of reviewing and assessing your completed application.  If your nomination is short listed, a representative from Thrombosis UK will then seek your permission to include your name on the summary paragraph included in the awards brochure and on the Thrombosis UK website.

Thrombosis UK takes security and confidentiality very seriously. Your name and contact details will never be passed or shared with any third party or an unauthorised individual. If you have any queries, please contact: [email protected]

Thrombosis UK VTE Awards
Application form

Applications are accepted on the basis that Thrombosis UK can share the content with external judges who will assist us with assessments. Service models, resources and working processes of successful Thrombosis UK VTE Award winners will be uploaded to the Thrombosis UK website and shared via publications, social media, and other opportunities.

When completing your application form, you should use lay language and answer each question in a concise manner. 

Please keep to any word limits given.

All sections need to be completed, if any section is removed, omitted or incomplete, we cannot process the application.

Applications need to be submitted via email to: [email protected] You will receive a notification of receipt within 48 hours of submission. If you do not receive a notification, please email [email protected]

The closing date for applications is 1st February 2025

We are unable to consider late applications.

Category
Thrombosis UK Award for Enhancing Patient Experience
Please note there is a separate application form for each category.
DATA PROTECTION

Thrombosis UK has a strict data protection policy that complies with UK data protection law.

Your name and contact details may be stored for up to 12 months in order for correspondence relating to your application be appropriately processed.

 

We wish to make you aware that your name and contact details, as included on your completed application form, will be viewed by the Thrombosis UK appointed Judging Panel solely for the purpose of reviewing and assessing your completed application.  If your nomination is short listed, a representative from Thrombosis UK will then seek your permission to include your name on the summary paragraph included in the awards brochure and on the Thrombosis UK website.

Thrombosis UK takes security and confidentiality very seriously. Your name and contact details will never be passed or shared with any third party or an unauthorised individual. If you have any queries, please contact: [email protected]

Thrombosis UK VTE Awards
Application form

Applications are accepted on the basis that Thrombosis UK can share the content with external judges who will assist us with assessments. Service models, resources and working processes of successful Thrombosis UK VTE Award winners will be uploaded to the Thrombosis UK website and shared via publications, social media, and other opportunities.

When completing your application form, you should use lay language and answer each question in a concise manner. 

Please keep to any word limits given.

All sections need to be completed, if any section is removed, omitted or incomplete, we cannot process the application.

Applications need to be submitted via email to: [email protected] You will receive a notification of receipt within 48 hours of submission. If you do not receive a notification, please email [email protected]

The closing date for applications is 1st February 2025

We are unable to consider late applications.

Category
Thrombosis UK Award for advancing awareness and information sharing of cancer acquired thrombosis (CAT)
Please note there is a separate application form for each category.
DATA PROTECTION

Thrombosis UK has a strict data protection policy that complies with UK data protection law.

Your name and contact details may be stored for up to 12 months in order for correspondence relating to your application be appropriately processed.

 

We wish to make you aware that your name and contact details, as included on your completed application form, will be viewed by the Thrombosis UK appointed Judging Panel solely for the purpose of reviewing and assessing your completed application.  If your nomination is short listed, a representative from Thrombosis UK will then seek your permission to include your name on the summary paragraph included in the awards brochure and on the Thrombosis UK website.

Thrombosis UK takes security and confidentiality very seriously. Your name and contact details will never be passed or shared with any third party or an unauthorised individual. If you have any queries, please contact: [email protected]

Thrombosis UK VTE Awards
Application form

Applications are accepted on the basis that Thrombosis UK can share the content with external judges who will assist us with assessments. Service models, resources and working processes of successful Thrombosis UK VTE Award winners will be uploaded to the Thrombosis UK website and shared via publications, social media, and other opportunities.

When completing your application form, you should use lay language and answer each question in a concise manner. 

Please keep to any word limits given.

All sections need to be completed, if any section is removed, omitted or incomplete, we cannot process the application.

Applications need to be submitted via email to: [email protected] You will receive a notification of receipt within 48 hours of submission. If you do not receive a notification, please email [email protected]

The closing date for applications is 1st February 2025

We are unable to consider late applications.

Category
Thrombosis UK Award for work in VTE Prevention
Please note there is a separate application form for each category.
DATA PROTECTION

Thrombosis UK has a strict data protection policy that complies with UK data protection law.

Your name and contact details may be stored for up to 12 months in order for correspondence relating to your application be appropriately processed.

 

We wish to make you aware that your name and contact details, as included on your completed application form, will be viewed by the Thrombosis UK appointed Judging Panel solely for the purpose of reviewing and assessing your completed application.  If your nomination is short listed, a representative from Thrombosis UK will then seek your permission to include your name on the summary paragraph included in the awards brochure and on the Thrombosis UK website.

Thrombosis UK takes security and confidentiality very seriously. Your name and contact details will never be passed or shared with any third party or an unauthorised individual. If you have any queries, please contact: [email protected]

Skip to content